Douglas R Wassenaar
Affiliation: University of KwaZulu-Natal
Country: South Africa
- Improving understanding of clinical trial procedures among low literacy populations: an intervention within a microbicide trial in MalawiPaul M Ndebele
HJF DAIDS, NIAID, NIH, 6700A Rockledge Drive Room 42A193, Second Floor, Bethesda, MD 20817, USA
BMC Med Ethics 13:29. 2012..The narrative used daily examples from the field of Agriculture because Malawi has an agro-based economy...
- The use of students as participants in a study of eating disorders in a developing country: case study in the ethics of mental health researchDouglas Richard Wassenaar
School of Psychology, University of KwaZulu Natal, KwaZulu Natal, South Africa
J Nerv Ment Dis 200:265-70. 2012..The study underlines the need for special ethics scrutiny of mental health-related research proposals involving students as research participants, especially when conducted by their own teachers...
- Convergent ethical issues in HIV/AIDS, tuberculosis and malaria vaccine trials in Africa: Report from the WHO/UNAIDS African AIDS Vaccine Programme's Ethics, Law and Human Rights Collaborating Centre consultation, 10-11 February 2009, Durban, South AfricaNicole Mamotte
African AIDS Vaccine Programme s Ethics, Law and Human Rights Collaborating Center, School of Psychology, University of KwaZulu Natal, Pietermaritzburg, South Africa
BMC Med Ethics 11:3. 2010..However, conducting HIV/AIDS, TB, and/or malaria vaccine trials simultaneously in developing countries, or in populations affected by all three diseases, is likely to result in numerous ethical challenges...
- The ethical involvement of women in HIV vaccine trials in Africa: discussion paper developed for the African AIDS Vaccine ProgrammeDouglas R Wassenaar
Ethics Law and Human Rights Working Group ELH, WHO UNAIDS sponsored African AIDS Vaccine Programme, School of Psychology, Scottsville, Pietermaritzburg, South Africa
Women Health 45:37-50. 2007....
- A developing country response to Lavery et al. "In global health research, is it legitimate to stop clinical trials early on account of their opportunity costs?"Douglas R Wassenaar
Biomedical Research Ethics Committee, University of KwaZulu Natal, Durban, South Africa
BMC Med Ethics 10:16. 2009..A recent paper presents an argument and mechanism for the possible stopping of clinical trials early based on opportunity costs...
- One step forward, two steps back--requiring ministerial approval for all "non-therapeutic" health research involving minorsAnn E Strode
HIV AIDS Vaccines Ethics Group HAVEG, School of Law, University of Kwa Zulu Natal, Pietermaritzburg, South Africa
S Afr Med J 97:200-2. 2007..We accept the disadvantages, namely that the same body will review protocols twice from slightly different perspectives and that certain categories of research will remain unapprovable...